PACLITAXEL FORMULATIONS, DOSING REGIMENS AND ADMINISTRATION TO REDUCE HYPERSENSITIVITY REACTIONS

• 1. 用于治疗子宫肌瘤并减少月经失血的促性腺激素释放激素拮抗剂给药方案 [P] . 中国专利： CN110996957A . 2020-04-10
• 2. 一种配方颗粒剂给药管理方法 [P] . 中国专利： CN112837780A . 2021-05-25
• 3. Method for reducing influenza-like symptoms associated with intramuscular administration of interferon using a rapid dose-adjusting, incremental dosing regimen [P] . 日本专利： JP6522069B2 . 2019-05-29

  机译： 使用快速剂量调节，增量给药方案减轻与肌肉注射干扰素有关的流感样症状的方法

• 4. METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN [P] . 美国专利： US2020046804A1 . 2020-02-13

  机译： 快速滴定分级给药方案减少与肌内注射干扰素有关的感冒症状的方法

• 5. Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen [P] . 美国专利： US10500254B2 . 2019-12-10

  机译： 用快速滴定递增给药方案减轻与肌肉注射干扰素有关的流感样症状的方法

• 1. A COMPARATIVE STUDY OF INTRAVENOUS ACCELERATED STREPTOKINASE DOSE REGIMEN WITH CONVENTIONAL DOSE REGIMEN FOR CORONARY THROMBOLYSIS [J] . 张钧华, 邵耕, 崔亮, 中国医学科学杂志：英文版 . 1996,第004期
• 2. Evaluation of the tumor load and adverse reactions of nedaplatin combined with paclitaxel liposome and with paclitaxel treatment of advanced esophageal cancer [J] . Jun-Ying Liang, Mao-Nan Yang 海南医科大学学报（英文版） . 2017,第008期
• 3. Evaluation of the tumor load and adverse reactions of nedaplatin combined with paclitaxel liposome and with paclitaxel treatment of advanced esophageal cancer [J] . Jun-Ying Liang, Mao-Nan Yang 海南医科大学学报(英文版) . 2017,第008期
• 4. Dose-dense paclitaxel plus carboplatin vs.epirubicin and cyclophosphamide with paclitaxel as adjuvant chemotherapy for high-risk triple-negative breast cancer [J] . Qing Li, Ying Fan, Pin Zhang, 中国癌症研究（英文版） . 2020,第004期
• 5. An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions. [J] . Markman M, Kennedy A, Webster K, Journal of Cancer Research and Clinical Oncology . 1999,第7期
• 6. Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens [J] . J S Kloover, M A den Bakker, H Gelderblom, British Journal of Cancer . 2004,第2期
• 7. Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation [J] . WangH., ChengG., DuY., Molecular medicine reports . 2013,第3期
• 8. A Biodistribution Study of a Porous Microsphere Formulation of Paclitaxel (AI-850)Following Intravenous Administration in Rats [C] . Julie Straub, Donald Chickering, Jonathan Lovely, Controlled Release Society annual meeting . 2004
• 9. Inhibition of lipid mediators in type I (immediate) hypersensitivity immune reactions by conjugated linoleic acid (CLA). [D] . Whigham, Leah Dawn. 2000
• 10. Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens [O] . J S Kloover, M A den Bakker, H Gelderblom, 2004
• 11. Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens [O] . Kloover, J S, Bakker, M A den, Gelderblom, H, 2004

• 1. Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction [J] . M Wasif Saif ,Shailja Roy ,Leslie Ledbetter . 世界胃肠病学杂志：英文版 . 2007,第39期
• 2. 一种减少802.16j信号开销和等待时间的服务流程管理方案 [C] . 张峻恺 ,冯穗力 ,杨劲松 . 2011广东通信青年论坛 . 2011
• 3. 氨甲环酸的不同给药方案对减少全髋关节置换术围术期失血的研究 [A] . 赵帅 . 2017